chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022; No Adverse event; Administered the vaccine to patient after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022) and NO ADVERSE EVENT (No Adverse event) in a 58-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022).    No Concomitant medication reported. Patient received half dose. The vial did not undergo any temperature excursions. No Treatment medication reported.
Injection site pain, spreading throughout arm on same day as shot. Next day increased site pain, minor to mederate light headedness with vertigo that lasted severel hours. General fatigue with fever of 99.9 most of day. By 04/09 only experiancing decresed arm pain with minor fatigue.
I experienced a rash about three weeks after my J&J vaccine. I also experienced a full body rash, not on my palms or soles of my feet or face but I did have the rash everywhere else. It was itchy, on a scale 6-7 out of 10 on VAS scale, persistent, pervasive and my PCP diagnosed me with pyrethrum rosacea. There was a patch on my back examined by my PCP.  My PCP told me it would go away on its own, also gave me a prescription Aciclovir, low dose (25mg) for treatment.  As far as today, my rash is still present, comes and goes and I have mild itchiness in more areas of my body and also the back of my knees.
Migraine spiked to 10 Whole body muscle & joint pain making it difficult to move about  & severe pain w/ limited mobility at injection site Stomach cramping  Nausea  Significantly increased Brain Fog & trouble verbally communicating  Emotional  - did not experience any symptoms after 1st injection FC3181  from Walgreens though was diagnosed with Hashimotos since 1st dose which also results in similar side effects though I?m 99% worse since getting 2nd dose yesterday
Patient is mistakely given moderna rather than pfizer,patient is 15 years old.; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is mistakely given moderna rather than pfizer,patient is 15 years old.) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is mistakely given moderna rather than pfizer,patient is 15 years old.). On 07-Sep-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient is mistakely given moderna rather than pfizer,patient is 15 years old.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.
Pneumococcal polysaccharide (PPV 23) on 8/28/07. 8/28: general soreness arm. 8/29 Sharp arm pain/red/swollen, very tired (took 2 Darvocet). 8/30 99.8 fever, extreme arm pain and neck, shoulder, armpit sore and can't move; 1 single hive (nickel size), swollen and very tender to touch/red and hot; 8/31/07 99.3, more hives 6 inches around inject site/flushed/dizzy/hard to swallow/skin peeling. Took Benadryl 2x later Darvocet/Ice. 9/1/07 Red, swollen less pain. 9/2/07 better.
Neuralgia - diffuse, non specific, 24 hr onset (8/7/12). Neurology -> consult cannot r/o acute ascending sensory polyneuropathy. No evidence of motor disorder.
Patient received Moderna COVID-19 vaccine dose 1 on 6/8/2022, Moderna COVID-19 vaccine dose 2 on 7/1/2022, diagnosed with COVID-19 via positive test on 9/22/22, and on 10/12/22 was admitted for multisystem inflammatory syndrome in children (MIS-C). Reporting for MIS-C occurring after COVID-19 vaccination.
patient received the "HPV vaccine" and experienced "lethargy, irregular lab results, and a potential diagnosis of Lupus"; patient received the "HPV vaccine" and experienced "lethargy, irregular lab results, and a potential diagnosis of Lupus"; patient received the "HPV vaccine" and experienced "lethargy, irregular lab results, and a potential diagnosis of Lupus"; This spontaneous report was received from a consumer via a company representative, referring to a female patient of unknown age. The patient's pertinent medical history, drugs reactions or allergies and concomitant medications were not reported.  On an unknown date in October 2019, the patient was vaccinated with an HPV vaccine (manufacturer unknown) (dose, frequency, route of administration, anatomical location, lot number and expiration date were not reported).  On an unknown date, the patient experienced lethargy (lethargy), irregular lab results (unspecified) (laboratory test abnormal) and a potential diagnosis of lupus (systemic lupus erythematosus). It was not reported, if the patient sought medical attention, if any treatment was given for the events, or if any laboratory diagnostics or studies were performed. At the reporting time the outcome of the adverse events was unknown.  The causal relationship between and the aforementioned adverse events and HPV vaccine (manufacturer unknown) was reported by the patient's mother as might be a cause but was not confirmed by the treating physician.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2007USA010586:
Severe headache and sore arm.  I have had this headache for almost 10 months.  I have recently started to have a ringing in my ears.  Dr thought I had a sinus infection.  I have taken 5 rounds of antibiotics, the last one I finished a week ago.  They have had no effect. There is a feeling of "fullness" in my head.  My nose, the areas around my eyes and my forhead hurts.  It is a throbbing pain.  When I cough or sneeze, I have a sharp pain in the right top of my head that brings tears to my eyes!  I had a CT scan in May.  It showed nothing unusual.  I saw an EN&T doctor on Friday 9/7/07.  She ran a tube with a light on the end up my nose and did not see anything unusual.  I want to find out if this is a result of the vaccine before I have anymore tests done.  I am thinking about requesting a referral to a neurologist and a diagnostic MRI.
The patient received the vaccine and was waiting her 15 minutes to make sure she didn't have any reactions. Approximately 8 minutes after the vaccine was administered and the patient passed out . She did not report that she was not feeling well until after she came to. She then reported dizziness and nausea. She laid on the floor in the recovery position on the floor for about 30 minutes before feeling ok enough to sit in the chair and eventually be able to walk out of the store.
This spontaneous report was received from a nurse and refers to two patients who are over 65 year old. No information regarding the patients' pertinent medical history, concomitant therapies and drug reaction or allergies was provided. On an unknown date in 2018 (reported as within the past 6 months), the patients were vaccinated with PNEUMOVAX23 (exact dose, route of administration, lot# and expiry date were not reported) for prophylaxis. On an unknown date in 2018, the patient experienced serious (severe) injection site reactions after receiving PNEUMOVAX23, including swelling, redness, pain, tenderness, and rash. No prescription drug treatment was given for the event. The outcome of the events was reported as recovered on an unknown date in 2018. Causality assessment was not provided.
patient experienced syncopal episode approx 24 hours after vaccine administration. required evaluation in ED and was ultimately discharged after testing and observation.
I contracted Covid19 5/7/2022 with symptoms of runny nose, headache, myalgia, fatigue, congestion, and cough. I was prescribed Paxlovid 5/10/2022 and my symptoms are improving.
Follow up information provided updated patient and reporter demographics, dates of administration and additional vaccines administered and updated details regarding patient diagnosis, including additional diagnosis and recovery status and lot numbers. Information regarding Prevnar was received from a nurse regarding a now, 5 year old male patient who, at 17 months of age, received a second dose of Prevnar, a first dose of Varivax, and a third dose of IPOL on 5/17/01. In January 2005, the child was diagnosed with bilateral otitis media, an upper respiratory tract infection, influenza, and developed pneumococcal meningitis. Relevant medical history reported as none. Indication for Prevnar was immunization. Product was administered on 5/17/01. Dose regimen was 0.5ml  1 time per day. Concomitant therapy included Varivax and IPOL. On 5/17/01, a 17 month old male received a second dose of Prevnar. On 1/20/05, at 5 years of age, the child was evaluated and diagnosed with bilateral otitis media and an upper respiratory tract infection. Treatment included Omnicef and Motrin. On 1/22/05, he was evaluated at a local urgent care and diagnosed with influenza after a rapid test was positive. On 1/24/05, he was evaluated in the physician's office after developing increased ear pain and nuchal rigidity. The child was sent to the emergency room where he was admitted to the pediatric intensive care unit. On 1/24/05, Streptococcus pneumoniae was confirmed. On 1/28/05, the patient developed intractable seizures and was placed  in a coma. On 2/1/05, the pentobarbital was weaned. On 2/8/05, an external shut was placed. The reporter considered the events of meningitis pneumococcal, drug ineffective, and convulsions to be life threatening, resulting in persistent or significant disability. As of 2/23/05, the patient had not recovered and remained hospitalized.
SWELLING OF THE THROAT; HIVES OF THROAT; FEVER; HEADACHE; SHORTNESS OF BREATH; SWEATING; LEFTOVER 6TH DOSE WAS ADMINISTERED TO PATIENT; This spontaneous report received from a patient concerned a 47 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 29-MAR-2021 14:00 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On JAN-2021, Laboratory data included: COVID-19 virus test positive (NR: not provided) Positive. On MAR-2021, Laboratory data included: Oxygen saturation (NR: not provided) 93. Treatment medications included: acetylsalicylic acid, diphenhydramine hydrochloride, and paracetamol. On 29-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 104 F. On 29-MAR-2021 14:00, the subject experienced leftover 6th dose was administered to subject. On 30-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 102.9 F. On 30-MAR-2021 04:00, the subject experienced shortness of breath. On 30-MAR-2021 04:00, the subject experienced sweating. On 30-MAR-2021 04:00, the subject experienced swelling of the throat. On 30-MAR-2021 04:00, the subject experienced hives of throat. On 30-MAR-2021 04:00, the subject experienced fever. On 30-MAR-2021 04:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling of the throat, and hives of throat on 30-MAR-2021 at around 10:00, was recovering from shortness of breath, had not recovered from headache, fever, and sweating, and the outcome of leftover 6th dose was administered to patient was not reported. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious
Having Peeing / semi diarrhea problems. Lucky I had a catheter with me; first time needed in a year. Semi diarrhea was something new. Did not eat anything  after breakfast, fruit as usual that morning. Bad Headache went away after 48 hours. Felt good after that. Had no fever, ever.
The booster that they gave me was expired, they told me that manufacturer let me know it wasn't a problem, but I still would like to get a dose that wasn't expired. I started having face flushing and it felt like was running a fever, but I wasn't, my; face was really red, and it would happen from when I woke up. This started the first week of November. My stomach has been bothering me that I ended up in urgent care on Nov 14. As of today, I'm not flushing, and my stomach feels better. I saw my doctor on 9th of November because of the flushing, she wasn't sure what was going on. They just told me to drink more water and electrolytes.
Patient came in for a visit around 2pm on 9/20/21.  Gave injection and pt tolerated well.  Patient called this morning stating that she has a fever, body aches and stated that  she can not move her arm where shot was injected. Spoke with family practice manager and was advised that this was a side effect from the vaccine. Spoke with patient and advised her that is these symptoms continue to give us a call and we will do a follow appointment with her.
Redness, swelling, warm to touch and pain,  Zyrtec 10mg given, Prednisone 30mg PO GIVEN
third full shot of Moderna vaccine after having two shots of Pfizer vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (third full shot of Moderna vaccine after having two shots of Pfizer vaccine) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (third full shot of Moderna vaccine after having two shots of Pfizer vaccine). On 01-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (third full shot of Moderna vaccine after having two shots of Pfizer vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
This case was reported by a healthcare professional via sales representative and described the occurrence of not responding to therapy in an adult female subject who was vaccinated with hepatitis B (manufacturer unspecified). In the 1990's, possibly 1995 the subject received hepatitis B vaccine series (unknown). On an unspecified date, after vaccination with hepatitis B vaccine, the subject experienced not responding to therapy. The sales representative reported an adult employee received hepatitis B series in 1990's, possibly in 199. Upon hiring, her hepatitis titer was drawn and came back negative. At the time of the report no adverse events occurred.
Pt had a GI bleed and increasing respiratory symptoms.  Pt tested positive for COVID.  Pt ultimately passed.
States she has a headache which started about 15 minutes after she received the intranasal vaccine. State headache has remained the same
Large golfball-sized knot at the site of administration apporox. 8 days after recieving the vaccine. This was patient's 6th dose of the anthrax vaccine.
Approximately  6 days after vaccine the injected arm became very itchy and inflamed  with large red  area around site about  4-5 inches diameter and hard tissue  under skin.  Soreness and discomfort around area extended  into shoulder.  .  These reactions  persisted for about 12 days and have mostly abated, with a small residual red area and occasional itching.
I received my initial COVID vaccine Mar 2021 and received the J and J (no side effects).   Received the Pfizer booster Nov 1, 2021.  No side effect the first day.   The second day I started getting the chills, body aches and slight fever.   The third day all side effects gone.   The morning of the 4th day, my lymph node was very enlarged in  my armpit in the same arm I received the booster shot.  On Nov 30th, I went to my primary care provided because the lymph node, although greatly reduced in size, is still enlarged and sore.
Information has been received from a consumer concerning herself a 72 year old female with non-hodgkin's lymphoma and allergic reaction to erythromycin (nausea) who on 02-APR-2007 was vaccinated subcutaneously with a dose of Zostavax. Concomitant therapy included TOPROL XL TABLETS and PREMARIN. Two days after receiving the vaccination on 04-Apr-2007, she began to feel "achy all over". Then, a day or two later, she began to have significant pain in both of her ears and her ears were "tender to the touch". Also her skin felt "tingly" particularly on her left arm. Presently, the tingling on her skin was gone away, but she is still experiencing intermittent pain in her right ear only. The patient did not seek medical attention. No laboratory test were performed. No product quality complaint. Additional information has been requested. Follow-up information received from the physician stating that the patient has not reported any problems. No further information is available.
postherpetic neuralgia; other zoster related injuries; shingles; Initial information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown gender who at the time of vaccination with zoster vaccine live (ZOSTAVAX) was 72 years old. No information about the pt's medical history, concurrent conditions or concomitant medications was provided. On or about 13-JUL-2012, the pt was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) by a healthcare provider at a healthcare facility for the long-term prevention of shingles and zoster-related conditions. Subsequently, on unknown dates, the pt was treated by physicians at a healthcare facility, and by other healthcare providers, for the following injuries resulting from the pt's zoster vaccine live (ZOSTAVAX) use: shingles, postherpetic neuralgia, and other zoster related injuries. The outcome of the events was not provided. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
Dtap vaccine administered-12-24 hr after administration-red warm cellulitis appearing rash with vesicular papular eruption approximately 3 in x 3 in in size at injection site-new areas to buttocks, back, and chest with similar presenting pattern. Resolved in 3 days with BENADRYL.
This spontaneous report as received from a physician via an unspecified reporter through a company representative, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 23-JAN-2015, the patient was vaccinated with VAQTA "25U/.5ML 10x1 (ped), lot # J000985 with expiration date 20-AUG-2015 (route of administration unknown), which was stored at -1 Celsius Degrees F for 24 hours, at 1 Celsius degrees for 48 hours and at 9 Celsius degrees for 72 hours. The storage criteria and the type of excursion was refrigerator (R) and the vaccine status was reported as "in excursion". There were no concomitant therapies and adverse effects reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Rash, sore throats, h/a, muscle & joint pain & tenderness, tingling sensation & numbness to both arms & hands, fatigue, initial flu-like sx lasted about 1 wk; Tx rest & aspirin or APAP given only limited relief;
Patient received his Moderna COVID vaccines on 2/2 and 3/2, he reported feeling like he had the flu for about a week, 6-7 days after the second dose. He experienced severe chills, rapidly changing temperature from 94 to 100.4, and diarrhea, he reported "feeling the vaccine go through each body system."
Client received Td vaccine 10-25-05. Client presented at mass influenza vaccine clinic on 10-29-05 & shared with flu vaccinator the left deltoid area with large local reaction where Td given.  Counseled by flu vaccinator to see her medical provider.  On 11-03-05 follow-up phone call to client by Td vaccinator, client verbalized symptoms started evening of 10-26-05 "hard red knot, hot to touch, shortness of breath, fever, dry heaves.  Late night Thursday (10-27-05) stiff arm and neck.  Client did not go for medical evaluation as advised by flu vaccinator on 10-29-05 but self medicated with Keflex Saturday 10-29-05. Instructed again to seek medical evaluation ASAP.  11/09/05: follow-up phone call by Td vaccinator.  Client states had follow-up visit to Dr.  He stated the site looked infected and prescribed 5 days of Keflex.  Client reported redness and knot gone.
Numbness on the left side of my neck all the way up to my eye, and pain in my port site. I monitored my symptoms for 2 d5ays and they eventually went away.
Immunization (MMR and Prevnar) given 4/20/06 1 week later developed fever x5 days as high as 105. Seen in ER. Also had diarrhea x several days. Fever gone, diarrhea resolving. Rash started 4/29 1-2mm red/raised lesions in trunk area.